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INTRODUCTION
In the modern world, cardiovascular diseases are one of the main causes of mortality among the population. The purpose of our work was the search for safe and effective biologically active substances of cardiotropic action among 1,3-thiazole derivatives. Scientists who have been working in this direction have received great results [1, 2] . But despite a large number of publications, there is practically no information in the literature on the physical, chemical and biological properties of compounds that have piperazine, morpholine and 1,3-thiazole cycles together in their structure. Since in modern medicine there are some examples of the successful use of medications based on these heterocycles, we considered it expedient to combine these known pharmacophores in one molecule [3, 4, 5] .
The presence of several heterocycles in the structure of the planned compounds can lead either to synergism of the biological effect or to the appearance of new pharmacological effects In addition, in order to determine the structural and biological patterns, it was planned to introduce thiazole ring radicals with different alkyl chain lengths into the 3rd position between the nitrogen of the 1,3-thiazole, morpholine and piperazine cycles.
MATERIALS AND METHODS
In the course of the work, the required reagents were obtained and purified by standard techniques. 3-сhlorpentane-2,4-dione, ethyl-2-chlor-3-oxobutanoate, ethyl 2-bromo-3-oxobutanoate, piperazine ethylamine, 4-methylpiperazinamine, 3,4-dimethoxyphenylethylamine and morpholinethylamine were purchased from Acros Organics and used without further purification. R-phenyl isothiocyanates were synthesized by aromatic amines treatment using tetramethylthiuram disulfide followed by destruction of transition product of N (1) -aryl-N,N-dimethylthiourea under the action of concentrated HCl [6] . The elemental analysis of the nitrogen content was performed using the Duma's method. 1 H NMR spectra were recorded on a Varian Gemini 400 MHz spectrometer; tetramethylsilane (TMS) was used as an internal standard.
The studies were performed on mature female rats weighing 267 ± 11.2 g, which were on the standard PC "Biomodel Service" diet at a free access to food and water. All experimental studies were carried out accordingly to the European Convention on Animals Protection (1986), the "Regulations on the Use of Animals in Biomedical
Research" (1989) .
Before the experiment starting, the animals were set apart without access to food and water for an hour to standardize the stress state in experimental studies. Then, the animals were weighed and euthanized by decapitation under light ether anesthesia accordingly to the European Convention on Animals Protection.
The cardiotropic properties of the new 1,3-thiazole derivatives were studied on the isolated rings of the thoracic aorta of laboratory rats. The target organ was removed immediately from the dead animal and was placed in Krebs solution of the following composition (in mmol / l): NaCl-132; KCl-4.7; NaH 2 PO 4 · 2H 2 O-1.4; NaHCO 3 -16.3; CaCl 2 -2.5; MgCl 2 • 2H 2 O-1.05; glucose-6.5. Aeration of the solution was carried out with carbogen (gas mixture 5% CO 2 / 95% O 2 ) [7] .
Further, the biological material was placed on a paraffinic operating table in the Krebs solution at a room temperature. After fixation with hooks, the biological material was cleaned from fat and connective tissues. The smooth muscle preparations purified were cut into rings with width of 1 mm at an angle of 45 °. The isolated and purified isolated rings of the thoracic aorta of rats were secured in a flow chamber (myographic unit) on two steel hooks with a previous load of 1.5 g. A 0. mol/l) for 10 to 15 minutes to achieve the constriction plateau, following which Krebs solution was perfused, and the level of relaxation was observed. The mechanogram recorded whether the isolated vascular tone changed in under application of the test compounds, the normalized maximum rate of the contraction phase (Vnc) was calculated for hypoxia, the presence of any contraction in case of phenylephrine, and the level of relaxation a were analyzed t the end of the experiment [7, 8, 9, 10] , were chosen as reference products.
RESULTS AND DISCUSSIONS
As initial substances to synthesize new derivatives of 1-
were used, which were synthesized by reaction between R-phenyl isothiocyanates and arylamines substituted by piperazine amines and morpholinamines in equimolar amounts in a dry dioxane medium [11, 12, 13] . The hydrochlorides 1- The essence of the method is to standardize the analysis of the mechanogram "contraction-relaxation" of smooth muscle organs, which does not depend on the size of the isolated smooth muscle preparation used in the experiment [7] .
During analysis of mechanokinetic curves, linearization of contraction phase This method allows to calculate indicators independent to the maximum forcestandardized value of the maximum contraction-rate Vn:
The effect of compounds examined on the contraction of isolated aortic thoracic rings for hypoxia were analyzed using the calculated normalized maximum rate of the contraction phase (Vnc -from the start of the muscle preparation strain increase to the maximum) in accordance with Formula 1.
While in vitro experiments, it was established that when the test compounds have been applied to isolated rings of the thoracic aorta of laboratory rats they have not caused constrictor responses of the latter, and for the two compounds, the decrease in vascular tone have been inherent. Such results confirm that there is no possible effect on hemodynamic parameters of the cardiovascular system in vivo studies, namely, systolic and diastolic arterial pressure, which is one of the key requirements at a cardioprotective drug development. Table 1 ).
Compound 4b, reduced the normalized maximum rate of the contraction phase for hypoxia on a par with the drugs of comparison, that from our point of view indicates the ability of this compound to realize a decrease in the energy potential of the cardiomyocyte damaged by hypoxia. Derivatives 6a, 7d, 8c also did not decrease, but accelerated by 0.5 times the normalized maximum rate of the contraction phase for hypoxia, which indicates the energy-consuming mechanism of their action.
( Figure 2 , Table 1 ).
As can be seen from the results of pharmacological research, the cardiotropic 2-[(4-methoxyphenyl)imin]-4-methyl-3-(4-methylpiperazine-1-yl)-2,3- 
1-[(2Z)-

dihydro-1,3-thiazole-5-yl]ethan-1-one hydrochloride 4a
To the 1.40 g of solution (0.005 mol) 1-(4-methoxyphenyl)-3-(4-methylpiperazine-1-yl)thiourea in 40 ml of ethanol a solution of 0.67 g (0.005 mol) of 3-chlorpentane-2,4-dione was added with stirring and boiled under reflux for 2 hours. After cooling, the solid that precipitated out was filtered off and crystallized from 2-propanol.
Yield: 67%, (2-propanol). Yield: 73%, (propanol-2). 
